| At birth | Hepatitis B, RSV. Newborn bloodspot, hearing, CCHD pulse oximetry, bilirubin and red reflex. |
|---|
| Age 3–5 days | First well-child visit: feeding, weight, jaundice. |
|---|
| Age 1 month | Hepatitis B (dose 2). Growth check. Maternal depression screening. |
|---|
| Age 2 months | DTaP, IPV, Hib, PCV, rotavirus. Growth check. |
|---|
| Age 4 months | DTaP, IPV, Hib, PCV, rotavirus |
|---|
| Age 6 months | DTaP, PCV, rotavirus (if 3-dose), hepatitis B (dose 3), IPV (dose 3). Yearly flu (and COVID per CDC) from this age. Oral health / fluoride. |
|---|
| Age 9 months | Developmental screening (ASQ). Anemia and lead risk assessment. |
|---|
| Age 12 months | MMR, varicella, PCV booster, Hib booster, hepatitis A (dose 1). Lead screening. |
|---|
| Age 15 months | DTaP (dose 4) |
|---|
| Age 18 months | Autism screening (M-CHAT). Hepatitis A (dose 2). |
|---|
| Age 24 months | Autism screening (M-CHAT, 2nd). BMI tracking begins. |
|---|
| Age 30 months | Developmental screening. |
|---|
| Age 3 years | Vision screening and blood pressure. Yearly from this age. |
|---|
| Age 4–6 years | DTaP, IPV, MMR, varicella (pre-school). Hearing and school readiness. |
|---|
| Age 6 years | Yearly well-child visit (BMI, blood pressure, vision and hearing). |
|---|
| Age 9–11 years | Lipid / cholesterol screening. |
|---|
| Age 11–12 years | Tdap, HPV, MenACWY. Yearly adolescent health, depression, and substance-use screening from this age. |
|---|
| Age 16 years | MenACWY booster, MenB series. HIV/STI screening. Lipid screening (young adult). |
|---|